← Leaderboards
Jan M. Van Deursen
Mayo Clinic Rochester
$15,959,798
Attributed
$16,097,096
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2008–23$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$16,097,096 · 13
By mechanism
R01$11,629,187 · 6
P01$2,902,938 · 1
P30$1,290,375 · 5
R43$274,596 · 1
Top collaborators
- Timothy Richard Stowe1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Jennifer J. Westendorf$18,995,005
- Darren Baker$10,907,779
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsBasePreventGenesMouse ModelTumorMolecularMutationTumorigenesisTransgenic MiceAneuploidyDesignKnock-OutChromosomesAllelesMitosisProgramsMitoticPhenotypeSeriesTissuesCancer CellMitotic Checkpoint
Grant awards (59)
Growth plate-targeted IGF1 to treat Turner Syndrome$274,596
R43 · FY2023 · HD · contact PI
Cellular senescence in aging and age-related disease.$349,800
R01 · FY2019 · AG · contact PI
BubRI in Cancer and Aging$329,666
R01 · FY2019 · CA · contact PI
Transgenic & Knockout Shared Resource$99,163
P30 · FY2019 · CA · contact PI
Cellular senescence in aging and age-related disease.$349,800
R01 · FY2018 · AG · contact PI
BubRI in Cancer and Aging$339,863
R01 · FY2018 · CA · contact PI
Transgenic and Knockout Core$70,367
P30 · FY2018 · CA · contact PI
Transgenic and Knockout Core$7,440
P30 · FY2018 · CA · contact PI
Transgenic and Knockout Core$6,548
P30 · FY2018 · CA · contact PI
Transgenic and Knockout Core$2,609
P30 · FY2018 · CA · contact PI
The role of senescent cells in late-life tumorigenesis$343,817
R01 · FY2017 · CA · contact PI
BubRI in Cancer and Aging$112,741
R01 · FY2017 · CA · contact PI
Transgenic and Knockout Core$71,099
P30 · FY2017 · CA · contact PI
Senescent Cell Clearance and Healthspan Extension$545,020
P01 · FY2016 · AG · contact PI
The role of senescent cells in late-life tumorigenesis$343,817
R01 · FY2016 · CA · contact PI
Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression$329,925
R01 · FY2016 · CA · contact PI
BubRI in Cancer and Aging$307,619
R01 · FY2016 · CA · contact PI
BUB1 in Chromosomal Instability and Tumorigenesis$293,037
R01 · FY2016 · CA · contact PI
Transgenic and Knockout Core$70,365
P30 · FY2016 · CA · contact PI
Senescent Cell Clearance and Healthspan Extension$530,137
P01 · FY2015 · AG · contact PI
The role of senescent cells in late-life tumorigenesis$343,817
R01 · FY2015 · CA · contact PI
Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression$329,925
R01 · FY2015 · CA · contact PI
BubRI in Cancer and Aging$307,619
R01 · FY2015 · CA · contact PI
BUB1 in Chromosomal Instability and Tumorigenesis$293,037
R01 · FY2015 · CA · contact PI
Transgenic and Knockout Core$72,270
P30 · FY2015 · CA · contact PI
Senescent Cell Clearance and Healthspan Extension$615,168
P01 · FY2014 · AG · contact PI
The role of senescent cells in late-life tumorigenesis$333,503
R01 · FY2014 · CA · contact PI
Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression$320,027
R01 · FY2014 · CA · contact PI
BubRI in Cancer and Aging$298,391
R01 · FY2014 · CA · contact PI
BUB1 in Chromosomal Instability and Tumorigenesis$284,246
R01 · FY2014 · CA · contact PI
Transgenic and Knockout Core$76,248
P30 · FY2014 · CA · contact PI
Senescent Cell Clearance and Healthspan Extension$583,802
P01 · FY2013 · AG · contact PI
The role of senescent cells in late-life tumorigenesis$358,567
R01 · FY2013 · CA · contact PI
Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression$310,130
R01 · FY2013 · CA · contact PI
BubRI in Cancer and Aging$289,162
R01 · FY2013 · CA · contact PI
BUB1 in Chromosomal Instability and Tumorigenesis$275,455
R01 · FY2013 · CA · contact PI
Transgenic$131,585
P30 · FY2013 · CA · contact PI
Senescent Cell Clearance and Healthspan Extension$628,811
P01 · FY2012 · AG · contact PI
Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression$329,925
R01 · FY2012 · CA · contact PI
BubRI in Cancer and Aging$307,619
R01 · FY2012 · CA · contact PI
Nucleoporins in Chromosomal Instability and Cancer$302,744
R01 · FY2012 · CA · contact PI
BUB1 in Chromosomal Instability and Tumorigenesis$293,037
R01 · FY2012 · CA · contact PI
Transgenic$162,091
P30 · FY2012 · CA · contact PI
Nucleoporins in Chromosomal Instability and Cancer$302,744
R01 · FY2011 · CA · contact PI
BubR1 in Cancer and Aging$292,335
R01 · FY2011 · CA · contact PI
Bub 1 in Chromosomal Instability and Tumorigenesis$272,764
R01 · FY2011 · CA · contact PI
Transgenic$136,122
P30 · FY2011 · CA · contact PI
Nucleoporins in Chromosomal Instability and Cancer$312,108
R01 · FY2010 · CA · contact PI
BubR1 in Cancer and Aging$301,377
R01 · FY2010 · CA · contact PI
Bub 1 in Chromosomal Instability and Tumorigenesis$281,200
R01 · FY2010 · CA · contact PI
Transgenic$143,898
P30 · FY2010 · CA · contact PI
Nucleoporins in Chromosomal Instability and Cancer$312,108
R01 · FY2009 · CA · contact PI
BubR1 in Cancer and Aging$301,377
R01 · FY2009 · CA · contact PI
Bub 1 in Chromosomal Instability and Tumorigenesis$281,200
R01 · FY2009 · CA · contact PI
Transgenic$142,066
P30 · FY2009 · CA · contact PI
Nucleoporins in Chromosomal Instability and Cancer$312,108
R01 · FY2008 · CA · contact PI
BubR1 in Cancer and Aging$301,377
R01 · FY2008 · CA · contact PI
Bub 1 in Chromosomal Instability and Tumorigenesis$281,200
R01 · FY2008 · CA · contact PI
CORE--ANIMAL MODELS$98,504
P30 · FY2008 · CA · contact PI